Meta-analysis of studies using metformin as a reducer for liver cancer risk in diabetic patients

Metformin has garnered more interest as a chemo-preventive agent given the increased liver cancer risk in diabetic patients. This work was undertaken to better understand the effect of metformin use on liver cancer risk in diabetic patients. A comprehensive literature search was performed in PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shujuan, Zheng, Yixiang, Xiao, Yanni, Zhou, Pengcheng, Tan, Hongzhuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428628/
https://www.ncbi.nlm.nih.gov/pubmed/28489794
http://dx.doi.org/10.1097/MD.0000000000006888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428628/
https://www.ncbi.nlm.nih.gov/pubmed/28489794
http://dx.doi.org/10.1097/MD.0000000000006888

Ejemplares similares